![Christoph Bausch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Christoph Bausch is the founder of Nanopore Diagnostics LLC.
Dr. Bausch is Chief Operating Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2017.
Dr. Bausch completed undergraduate studies at the University of Nebraska, earned an MBA from St. Louis University, and obtained a doctorate from The Ohio State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Director de Operaciones | 01/05/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Nanopore Diagnostics LLC
 Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 5 |
|---|---|
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanopore Diagnostics LLC
Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
